[go: up one dir, main page]

AR023869A1 - Gonadotropinas - Google Patents

Gonadotropinas

Info

Publication number
AR023869A1
AR023869A1 ARP000102182A ARP000102182A AR023869A1 AR 023869 A1 AR023869 A1 AR 023869A1 AR P000102182 A ARP000102182 A AR P000102182A AR P000102182 A ARP000102182 A AR P000102182A AR 023869 A1 AR023869 A1 AR 023869A1
Authority
AR
Argentina
Prior art keywords
gonadotropins
folliculogenesis
anovulatory women
hcg
fsh
Prior art date
Application number
ARP000102182A
Other languages
English (en)
Original Assignee
Serono Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8241371&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR023869(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Serono Lab filed Critical Serono Lab
Publication of AR023869A1 publication Critical patent/AR023869A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Uso de gonadotropinas en la induccion de foliculogenesis en mujeres anovulatorias. En particular, se relaciona con el uso de LH (o una dosis equivalente dehCG) en la produccion de un medicamento para inducir foliculogenesis en mujeres anovulatorias en dosis diarias especificadas. En ciertas realizaciones, LHpuede ser usado en conjuncion con FSH.
ARP000102182A 1999-05-07 2000-05-05 Gonadotropinas AR023869A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99303574 1999-05-07

Publications (1)

Publication Number Publication Date
AR023869A1 true AR023869A1 (es) 2002-09-04

Family

ID=8241371

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000102182A AR023869A1 (es) 1999-05-07 2000-05-05 Gonadotropinas

Country Status (18)

Country Link
US (2) US7695721B1 (es)
EP (1) EP1176976B2 (es)
JP (1) JP4975215B2 (es)
CN (1) CN1352566A (es)
AR (1) AR023869A1 (es)
AT (1) ATE332705T1 (es)
AU (1) AU4592800A (es)
BR (1) BR0010709B1 (es)
CA (1) CA2372714A1 (es)
DE (1) DE60029318T3 (es)
DK (1) DK1176976T4 (es)
ES (1) ES2267531T5 (es)
HK (1) HK1045261A1 (es)
IL (2) IL146252A0 (es)
PT (1) PT1176976E (es)
SI (1) SI1176976T2 (es)
TW (1) TWI242440B (es)
WO (1) WO2000067778A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1425032A2 (en) 2001-09-12 2004-06-09 Applied Research Systems ARS Holding N.V. USE OF hCG IN CONTROLLED OVARIAN HYPERSTIMULATION
AU2002324183B2 (en) * 2001-09-12 2007-10-25 Merck Serono Sa Use of hCG and LH in controlled ovarian hyperstimulation
WO2003022301A2 (en) * 2001-09-12 2003-03-20 Applied Research Systems Ars Holding N.V. Use of lh in controlled ovarian hyperstimulation
CN100376289C (zh) * 2001-09-12 2008-03-26 应用研究系统Ars股份公司 人绒毛膜促性腺激素和黄体生成激素在控制性超排卵中的应用
WO2004069271A1 (en) * 2003-02-07 2004-08-19 Austria Wirtschaftsservice Gesellschaft mit beschränkter Haftung Use of human chorionic gonadotropin in the treatment in the treatment of symptoms caused by endometriosis
US20040248784A1 (en) 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
ES2414705T3 (es) 2003-06-20 2013-07-22 Ares Trading S.A. Formulaciones liofilizadas de FSH/LH
TWI488640B (zh) 2008-04-16 2015-06-21 菲瑞茵國際中心股份有限公司 藥學製劑
TWI532495B (zh) * 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
WO2012016576A1 (en) 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone
PL2621517T5 (pl) 2010-09-29 2024-01-29 Ferring B.V. Kompozycja do stosowania w leczeniu niepłodności
WO2012127501A2 (en) * 2011-03-11 2012-09-27 Sanzyme Limited Composition for improving endometrial thickness during ovarian stimulation
AU2012286048A1 (en) 2011-07-18 2014-02-20 Arts Biologics A/S Long acting luteinizing hormone (LH) compound
US20150150497A1 (en) * 2012-07-18 2015-06-04 Mor Research Applications Ltd. Intrauterine device
US11389133B2 (en) 2016-10-28 2022-07-19 Samsung Electronics Co., Ltd. Method and apparatus for follicular quantification in 3D ultrasound images
US11376220B2 (en) 2017-06-30 2022-07-05 Therio, LLC Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals
IT202000022015A1 (it) * 2020-09-18 2022-03-18 Marca Antonio La Nuovo uso dell'ormone luteinizzante

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1197570B (it) * 1983-02-11 1988-12-06 Serono Ist Farm Miscele di fsh e lh da ipofisi porcine in rapporto definito
US4845077A (en) * 1984-04-03 1989-07-04 Serono Laboratories, Inc. Method of inducing ovulation
US4725579A (en) * 1985-02-21 1988-02-16 Serono Laboratories, Inc. Method of in vitro fertilization by a unique combination of gonadotropins
US5162306A (en) * 1987-01-23 1992-11-10 Donaldson Lloyd E Composition and method for producing superovulation in mammals
DK49987A (da) * 1987-01-30 1988-07-31 Nordisk Gentofte Fremgangsmaade til behandling af infertilitet og middel til anvendelse ved fremgangsmaaden
US5356876A (en) * 1992-01-13 1994-10-18 Trinity University Methods of terminating pregnancy
PT1135154E (pt) * 1998-12-01 2003-08-29 Akzo Nobel Nv Melhoria da foliculogenese

Also Published As

Publication number Publication date
BR0010709B1 (pt) 2011-11-29
EP1176976A1 (en) 2002-02-06
ATE332705T1 (de) 2006-08-15
JP2002544168A (ja) 2002-12-24
HK1045261A1 (zh) 2002-11-22
JP4975215B2 (ja) 2012-07-11
DE60029318D1 (de) 2006-08-24
DK1176976T3 (da) 2006-11-13
AU4592800A (en) 2000-11-21
CA2372714A1 (en) 2000-11-16
DE60029318T3 (de) 2016-03-10
PT1176976E (pt) 2006-11-30
CN1352566A (zh) 2002-06-05
US20040224895A1 (en) 2004-11-11
WO2000067778A1 (en) 2000-11-16
US7695721B1 (en) 2010-04-13
SI1176976T1 (sl) 2006-10-31
IL146252A (en) 2010-06-30
US7151083B2 (en) 2006-12-19
ES2267531T3 (es) 2007-03-16
DK1176976T4 (en) 2015-11-02
IL146252A0 (en) 2002-07-25
EP1176976B1 (en) 2006-07-12
EP1176976B2 (en) 2015-10-21
DE60029318T8 (de) 2007-11-22
ES2267531T5 (es) 2015-11-24
TWI242440B (en) 2005-11-01
BR0010709A (pt) 2002-06-04
DE60029318T2 (de) 2007-08-09
SI1176976T2 (sl) 2015-12-31

Similar Documents

Publication Publication Date Title
AR023869A1 (es) Gonadotropinas
HN1998000155A (es) Medicamentos
CO5680109A1 (es) Compuestos para el tratamiento de la disfuncion sexual femenina
AR032912A1 (es) Formulacion farmaceutica
AU1249902A (en) Effective antitumour treatments
PA8539901A1 (es) Novedosa sal de succinato de o-desmetil-venlafaxina
CL2008003939A1 (es) Uso de escitalopram o una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento de ansiedad social (divisional de la solicitud 1799-00).
SV2002000137A (es) Productos farmaceuticos beta-carbolina ref n. 29342/36539 el
SV2004001674A (es) Conjugacion y proceso para la preparacion de una hormona monopegilatada terminalmente-n para una hormona para el crecimiento humano ref. 01449/1
AR033031A1 (es) Tratamiento usando polipeptidos de neublastina
ATE248187T1 (de) Echinocandin-kohlenhydrate-komplexe
IT1319275B1 (it) Uso del baclofen nel trattamento dell'astinenza da etanolo.
UY25798A1 (es) Composición farmacéutica de liberación modificada que comprende un sensibilizador de insulina tiazolidinadiónico.
CO5200833A1 (es) Regimenes de dosificacion para lasofoxifeno
PE20011080A1 (es) Uso de mirtazapina para el tratamiento de trastornos del sueno
DE60006788D1 (de) Iod-herstellungszusammensetzung
IL148777A (en) Mirtazepine oral oral administration unit
KR880005928A (ko) 에브셀렌(Ebselen)의 새로운 의약적 용도
ITRM20010708A1 (it) Uso di una alcanoil l-carnitina per il trattamento della disfunzione erettile.
CY1107227T1 (el) Θεραπεια αυτοανοσων νοσων με εκχυλισμα αμερικανικου γκινσενγκ
ATE305796T1 (de) Präparationen von vitamin e in kombination mit afamin
UY26366A1 (es) Uso de (+)- tramadol, o demetiltramadol y/o (+) -o- demetiltramadol, o - desmetil-n-monodesmetil-tramadol, y/o (+) -o desmetil-n-monodesmetil-tramadol para la preparacion de un medicamento para el tratamiento de urgencia urinaria incrementada o incon
ES2158857T3 (es) Vacunas a base de estreptoquinasa.
IT1317885B1 (it) Uso di fibrati per la preparazione di un medicamento utile neltrattamento dell'insufficienza cardiaca congestizia.
DK1150683T3 (da) Anvendelse af dienogest i højere dosering

Legal Events

Date Code Title Description
FC Refusal